Annexin A13 Rekombinanter Antikörper
Annexin A13 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250350A5
Kat-Nr. : 85955-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
85955-1-PBS bindet in WB, Indirect ELISA Annexin A13 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | Annexin A13 fusion protein Ag18581 |
| Vollständiger Name | annexin A13 |
| Berechnetes Molekulargewicht | 316 aa, 35 kDa |
| Beobachtetes Molekulargewicht | 35 kDa |
| GenBank-Zugangsnummer | BC125158 |
| Gene symbol | Annexin A13 |
| Gene ID (NCBI) | 312 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Annexin A13 (ANXA13) is believed to be the original founder gene of the 12-member vertebrate annexin A family, and it has acquired an intestine-specific expression associated with a highly differentiated intracellular transport function (PMID: 11961095). ANXA13, which is highly expressed in the digestive system and believed to be the original founder gene of the annexin A family (PMID: 28423508). Limited evidence suggests that ANXA13 may play a role in apoptotic cell-mediated immunosuppression, hypertension, and cell death recognition (PMID: 28423508). ANXA13 is highly expressed in the human colon adenocarcinoma cell line HT29.



